The Pharmacokinetic and Pharmacodynamic Properties of Antitubercular Medications

PharmacokineticsPharmacokineticsand pharmacodynamicsPharmacodynamics operate in a partnership that can be used to maximize a drug’s potential for increasing treatment efficacyEfficacy, reducing side effectsSide effect, and minimizing drug interactionsInteractiondrug; maximizing these parametersParameter will help decide on an optimal dose, ideal administration timingTiming, and an appropriate frequency of the drug. We reviewed individual medicationsMedication used in active tuberculosisTuberculosisactive (TB), the pharmacokineticPharmacokineticsparametersParameter of relevance, and the association of pharmacokineticsPharmacokineticswith pharmacodynamicsPharmacodynamics with treatment efficacyEfficacy. First-line agentsAgentfirst-line, including rifamycins, isoniazid, pyrazinamidePyrazinamide, and ethambutolEthambutol, were evaluated on how to optimize their useAntibiotics. First-line agentsAgentfirst-line highlight the effectivenessEffectiveness of eradicating active TBTuberculosisactive by providing an effective dose from various pharmacokineticPharmacokinetics studies. Second-line antibioticsAntibioticsinclude moxifloxacinMoxifloxacin, amikacinAmikacin, cycloserineCycloserine, bedaquilineBedaquiline, and delamanidDelamanid. The unique pharmacokineticPharmacokinetics properties of each agent were explored. An overview of the standard doses is featured in this review, along with the pharmacokineticPharmacokineticsparameterParameter associated with efficacyEfficacy in addition to therapeutic drug monitoringMonitoring considerations. One of the factors that clinicians can manipulate in managing TB is the pharmacokineticPharmacokineticsparametersParametervia dosingDosingchanges, foodFoodadministration, managementManagement of drug interactionsInteractiondrug, and adherenceAdherence through directly observed therapy.